BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11385249)

  • 1. Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.
    Ebert M; Schandl L; Schmid RM
    Dig Dis; 2001; 19(1):32-6. PubMed ID: 11385249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.
    Boyd EJ; Rinderknecht H; Wormsley KG
    Int J Pancreatol; 1988 May; 3(4):229-40. PubMed ID: 3290345
    [No Abstract]   [Full Text] [Related]  

  • 3. [The differential diagnosis of chronic pancreatitis and pancreatic cancer].
    Brailski Kh; Mendizova A; Dinkov L; Damianov D; Glavincheva I
    Vutr Boles; 1989; 28(2):54-7. PubMed ID: 2669339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnosis of tumor-simulating pancreatitis and cancer of the head of the pancreas].
    Loginov AS; Sadokov VM; Isakova ZS; Sivash ES; Timoshina IV
    Sov Med; 1989; (10):93-6. PubMed ID: 2617352
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-morphological correlations of chronic pseudotumorous pancreatitis and cancer of the pancreas].
    Loginov AS; Sadokov VM; Chukunova BZ
    Klin Med (Mosk); 1992; 70(5-6):24-7. PubMed ID: 1434392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatitis and Pancreatic Cancer.
    Walling A; Freelove R
    Prim Care; 2017 Dec; 44(4):609-620. PubMed ID: 29132523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer.
    Yu J; Ohuchida K; Mizumoto K; Ishikawa N; Ogura Y; Yamada D; Egami T; Fujita H; Ohashi S; Nagai E; Tanaka M
    World J Gastroenterol; 2006 Jun; 12(24):3878-82. PubMed ID: 16804974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer in patients with chronic pancreatitis: a challenge from a surgical perspective.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 1999 Aug; 25(4):207-17. PubMed ID: 10448129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis.
    Wallrapp C; Hähnel S; Boeck W; Soder A; Mincheva A; Lichter P; Leder G; Gansauge F; Sorio C; Scarpa A; Gress TM
    Int J Cancer; 2001 Feb; 91(3):340-4. PubMed ID: 11169957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma.
    Olakowski M; Tyszkiewicz T; Jarzab M; Król R; Oczko-Wojciechowska M; Kowalska M; Kowal M; Gala GM; Kajor M; Lange D; Chmielik E; Gubala E; Lampe P; Jarzab B
    Folia Histochem Cytobiol; 2009; 47(2):249-55. PubMed ID: 19995712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.
    Standop J; Schneider M; Ulrich A; Mathiak G; Brand RE; Buechler MW; Pour PM
    Oncol Rep; 2004 Dec; 12(6):1309-15. PubMed ID: 15547756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function.
    Arvanitakis C; Greenberger NJ
    Lancet; 1976 Mar; 1(7961):663-6. PubMed ID: 73639
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-time quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders.
    Büchler P; Conejo-Garcia JR; Lehmann G; Müller M; Emrich T; Reber HA; Büchler MW; Friess H
    Pancreas; 2001 May; 22(4):331-40. PubMed ID: 11345132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic pancreatitis: diagnosis].
    Beglinger C
    Ther Umsch; 1996 May; 53(5):354-8. PubMed ID: 8685853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer.
    Ringel J; Löhr M
    Mol Cancer; 2003 Jan; 2():9. PubMed ID: 12556240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A solid pancreatic mass: tumour or inflammation?
    Frampas E; Morla O; Regenet N; Eugène T; Dupas B; Meurette G
    Diagn Interv Imaging; 2013; 94(7-8):741-55. PubMed ID: 23751230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.